<?xml version="1.0" encoding="UTF-8"?>
<p>In the light of the COVID-19 pandemic, some species of Artemisia including but not limited to 
 <italic>A. annua</italic>, 
 <italic>A. absinthium</italic>, 
 <italic>A. vulgaris</italic>, 
 <italic>A. maritima</italic> and 
 <italic>A. indhana</italic> are receiving greater attention from researchers as they hold great potential for their powerful anti-infectious, antiviral and anti-inflammatory activities [
 <xref rid="B6-medicina-57-00217" ref-type="bibr">6</xref>,
 <xref rid="B12-medicina-57-00217" ref-type="bibr">12</xref>,
 <xref rid="B46-medicina-57-00217" ref-type="bibr">46</xref>,
 <xref rid="B47-medicina-57-00217" ref-type="bibr">47</xref>,
 <xref rid="B48-medicina-57-00217" ref-type="bibr">48</xref>]. Recent studies are now pointing to the exciting roles of artemisinin and its derivatives (ARTs) as potential drug candidates against SARS-CoV-2 owing to their potent antiviral and anti-inflammatory properties. 
</p>
